67 related articles for article (PubMed ID: 10755535)
1. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant lymphoproliferative disorders in a cohort of adult patients with a liver transplant from a reference hospital in Bogotá, Colombia.
Jurado LF; Gómez-Aldana A; Tapias M; Cáceres D; Vera A; López-Panqueva RDP; Andrade RE
Biomedica; 2020 Sep; 40(3):498-506. PubMed ID: 33030828
[TBL] [Abstract][Full Text] [Related]
3. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.
Thomas de Montpréville V; Le Pavec J; Le Roy Ladurie F; Crutu A; Mussot S; Fabre D; Mercier O; Dorfmuller P; Ghigna MR; Fadel É
Respiration; 2015; 90(6):451-459. PubMed ID: 26506523
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.
Hatton O; Martinez OM; Esquivel CO
Pediatr Transplant; 2012 May; 16(3):220-9. PubMed ID: 22353174
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
[TBL] [Abstract][Full Text] [Related]
7. Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
Nalesnik MA; Rao AS; Zeevi A; Fung JJ; Pham S; Furukawa H; Gritsch A; Klein G; Starzl TE
Transplant Proc; 1997 May; 29(3):1905-6. PubMed ID: 9142315
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial Post-transplant Lymphoproliferative Disease in a Child.
Adair D; Sánchez-Jacob R; Heider A; Popova AP
Am J Respir Crit Care Med; 2020 Mar; 201(6):e19-e21. PubMed ID: 31647701
[No Abstract] [Full Text] [Related]
9. A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach.
Al-Maghrabi H; Hafiz B; Meliti A
Cureus; 2024 Feb; 16(2):e54407. PubMed ID: 38505446
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder.
Markouli M; Ullah F; Omar N; Apostolopoulou A; Dhillon P; Diamantopoulos P; Dower J; Gurnari C; Ahmed S; Dima D
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497432
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review.
Reiche W; Tauseef A; Sabri A; Mirza M; Cantu D; Silberstein P; Chandan S
World J Transplant; 2022 Aug; 12(8):268-280. PubMed ID: 36159076
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review.
Feng G; Li Q; Zhu H; Jiang Y; Yuan J; Fu Y; Deng Q
Front Oncol; 2021; 11():726134. PubMed ID: 34604065
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Naik S; Riches M; Hari P; Kim S; Chen M; Bachier C; Shaughnessy P; Hill J; Ljungman P; Battiwalla M; Chhabra S; Daly A; Storek J; Ustun C; Diaz MA; Cerny J; Beitinjaneh A; Yared J; Brown V; Page K; Dahi PB; Ganguly S; Seo S; Chao N; Freytes CO; Saad A; Savani BN; Woo Ahn K; Boeckh M; Heslop HE; Lazarus HM; Auletta JJ; Kamble RT
Transpl Infect Dis; 2019 Oct; 21(5):e13145. PubMed ID: 31301099
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey.
Karakoyun M; Önen Ş; Baran M; Çakır M; Ömür Ecevit Ç; Kılıç M; Kantar M; Aksoylar S; Özgenç F; Aydoğdu S
Turk J Gastroenterol; 2018 Jan; 29(1):89-93. PubMed ID: 29391313
[TBL] [Abstract][Full Text] [Related]
15. EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in
Bogusz AM
Case Rep Hematol; 2017; 2017():5083463. PubMed ID: 28487787
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.
Nijland ML; Kersten MJ; Pals ST; Bemelman FJ; Ten Berge IJ
Transplant Direct; 2016 Jan; 2(1):e48. PubMed ID: 27500242
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.
Mukthinuthalapati PK; Gotur R; Ghabril M
World J Hepatol; 2016 Apr; 8(12):533-44. PubMed ID: 27134701
[TBL] [Abstract][Full Text] [Related]
18. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.
Ali AS; Al-Shraim M; Al-Hakami AM; Jones IM
Open Virol J; 2015; 9():7-28. PubMed ID: 26862355
[TBL] [Abstract][Full Text] [Related]
19. The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.
Luskin MR; Heil DS; Tan KS; Choi S; Stadtmauer EA; Schuster SJ; Porter DL; Vonderheide RH; Bagg A; Heitjan DF; Tsai DE; Reshef R
Am J Transplant; 2015 Oct; 15(10):2665-73. PubMed ID: 25988622
[TBL] [Abstract][Full Text] [Related]
20. Current status of immunosuppression in liver transplantation.
Choudhary NS; Saigal S; Shukla R; Kotecha H; Saraf N; Soin AS
J Clin Exp Hepatol; 2013 Jun; 3(2):150-8. PubMed ID: 25755489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
